Neil Fullarton is a Scientist at Nebu-Flow, where he leads research into the nebulisation of biologics. His work supports the development of inhaled therapeutic macromolecules, including nucleic acids and other advanced modalities, by evaluating their structural and biological integrity post-nebulisation.
Neil has presented his research on biologics aerosolisation at conferences such as Respiratory Drug Delivery (RDD) and Drug Delivery to the Lungs (DDL). He has hands-on experience with aerosol recovery methods, physicochemical characterisation, and bioactivity assessments, utilizing techniques like ELISA and advanced functional assays.
He holds a BSc in Biomolecular Sciences from the University of Glasgow, with prior experience in molecular biology and assay development across clinical, academic, and commercial settings. Neil is focused on the translation of biologics for non-invasive pulmonary delivery and the advancement of nebuliser design for emerging classes of inhaled therapeutics.